For information about Africhol's programs and activities, please contact:
Latest News, Outbreak Notifications:
Follow Africhol on Twitter
CDC Advisory Committee On Immunization Practices Votes To Recommend Vaxchora, PaxVax’s Single-Dose Oral Cholera Vaccine
Businesswire (23 Jun 2016)
PaxVax today announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted yesterday on a recommendation for the use of Vaxchora™, a single-dose oral, live attenuated cholera vaccine indicated for use in adults 18 to 64 years of age.
Cholera vaccine study in Haiti suggests problems with current booster regimen
Medical Xpress (16 Jun 2016)
Cholera outbreaks are on the rise. To prevent and control them, three oral cholera vaccines are currently approved by WHO. A study published in PLOS NTDs examining the immune response to one of them in Haitian adults finds that while the first vaccine round elicits a strong cholera-specific response...
FDA approves vaccine to prevent cholera for travelers
FDA.gov (10 Jun 2016)
The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the prevention of cholera.
Silencing cholera's 'social media'
ScienceDaily (24 May 2016)
Bacteria use a form of 'social media' communication, quorum sensing, to monitor how many of their species are in the neighborhood. This is important in the pathogenicity of Vibrio cholerae, the cause of cholera. In a new study scientists explore the molecular mechanism whereby the quorum sensing response regulator LuxO regulates V. cholerae's pathogenicity.